Asensus Surgical Inc (NYSE American:ASXC)
| 0.696 BATS BZX Real-Time Price As of 12:40pm ET |  +0.016 / +2.35%Today’s Change | 0.35 Today|||52-Week Range 2.37 | -37.30% Year-to-Date |
| SECTOR Commercial Services | INDUSTRY Miscellaneous Commercial Services | MARKET CAP $160.8M |
Company Description
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System features a machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling on August 19, 1988 and is headquartered in Durham, NC.
Contact Information
Asensus Surgical, Inc. 1 TW Alexander Drive Durham North Carolina 27703 |
Employees
Shareholders
| Mutual fund holders | 8.17% |
| Other institutional | 7.41% |
| Individual stakeholders | 1.60% |
Top Executives
| Anthony Fernando | President Chief Executive Officer & Director |
| Shameze Rampertab | Chief Financial Officer & Executive Vice President |
| Cameron Pedersen | Vice President-Global Research & Development |
| Mark Klausner | Investor Relations Contact |
| Amanda Owens | Global Head-People |
